# Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses

> **NCT00841048** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 107 (actual)

## Conditions studied

- Diabetes Mellitus Type 2

## Interventions

- **DRUG:** AZD4017
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00841048
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** —
- **Final completion:** 2009-05
- **Target enrollment:** 107 (ACTUAL)
- **Last updated:** 2009-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00841048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00841048, "Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD4017 After Repeated Ascending Oral Doses". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00841048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*